EQT, a large investment firm based in Stockholm, is looking to sell its ownership stake in HMI Medical, a Singapore-based operator of private hospitals and clinics across Southeast Asia, at a price of roughly $600 million. According to The Wall Street Journal, the sale process has only just started.

HMI Medical runs hospitals and specialist clinics serving patients across Southeast Asia. The region is an attractive market for healthcare investors for a straightforward reason: the population is ageing, more people are moving into the middle class with money to spend on healthcare, and public hospitals are stretched thin. Those trends mean investors believe healthcare companies in this part of the world will keep growing.

EQT specializes in buying and selling companies. The firm has bought and sold healthcare businesses all over the world, and Southeast Asian healthcare has become one of the easier sectors to sell out of over the past few years. That matters because it signals there is real buyer demand.

A $600 million valuation opens the door to several types of buyers: healthcare companies already operating in the region, government investment funds focused on healthcare, and other large investment firms hunting for platforms to build bigger operations from. Singapore itself is known as a hub for regional medical care — patients fly in from across Southeast Asia and further afield for treatment there — which means hospitals and clinics based in Singapore can command higher prices than similar businesses in less prominent medical centers.

Here's what's important to keep in mind: the $600 million is a starting price, not a done deal. No buyer has made a binding offer yet. No shortlist of finalists has been announced. That figure represents what EQT hopes to get, not what the sale will necessarily close at. In Asia, early interest in deals like this often fades when it's time to put money on the table, and asking prices commonly shift between the time a sale process launches and the time it finishes. You should treat the $600 million as a rough signal of where things stand, not as the final price.

For any investment firm, selling a company follows a basic rule: funds have a lifespan, and the money raised has to go back to the investors who put it in within a set timeframe. Whether EQT faces a hard deadline for returning capital or is simply seizing the moment because buyers are keen right now is not publicly known.

The broader picture here is one of sustained deal-making in Southeast Asian healthcare. Companies in Malaysia, Indonesia, and Singapore have attracted serious investment money for over a decade. Large hospital operators like IHH Healthcare and Parkway have changed hands or brought in new part-owners. A successful sale of HMI at or near the $600 million asking price would suggest that investors still see real value in Southeast Asian healthcare, even though higher interest rates have made it harder for investment firms to get top dollar for companies in many other industries.

What happens next will depend on how the sale is run — whether EQT orchestrates a competitive auction or pursues quieter conversations with select buyers — and how those buyers weigh HMI's earnings power, debt level, and standing against both public hospital companies and other private hospitals that have recently changed hands. None of that information is public at this stage.

For now, the facts are simple: there is a seller, an early-stage process, and a $600 million target. The market will determine what actually happens.